Amanote Research
Register
Sign In
Figure 1: Distribution of Time Series Length for the 221 Time Series in the Evaluation Dataset.
doi 10.7717/peerj-cs.52/fig-1
Full Text
Open PDF
Abstract
Available in
full text
Date
Unknown
Authors
Unknown
Publisher
PeerJ
Related search
Combination Therapy With Dendritic Cells and Lenalidomide Is an Effective Approach to Enhance Antitumor Immunity in a Mouse Colon Cancer Model
Oncotarget
Oncology
Effective Antitumor Immunity Against Murine Gliomas Using Dendritic Cells Transduced With hTERTC27 Recombinant Adenovirus
Oncology Reports
Medicine
Cancer Research
Oncology
Natural Killer Cells Recruit Dendritic Cells to Promote Antitumor Immunity
Cancer Discovery
Oncology
Bone Marrow Vaccination: A Novel Approach to Enhance Antigen Specific Antitumor Immunity
Vaccine
Molecular Medicine
Public Health
Veterinary
Microbiology
Environmental
Immunology
Infectious Diseases
Occupational Health
Combination of Oncolytic Adenovirus and Luteolin Exerts Synergistic Antitumor Effects in Colorectal Cancer Cells and a Mouse Model
Molecular Medicine Reports
Oncology
Genetics
Molecular Biology
Biochemistry
Cancer Research
Molecular Medicine
Persistent, Antigen-Specific, Therapeutic Antitumor Immunity by Dendritic Cells Genetically Modified With an Adenoviral Vector to Express a Model Tumor Antigen
Gene Therapy
Molecular Medicine
Genetics
Molecular Biology
Combined mTOR and MEK Inhibition Is an Effective Therapy in a Novel Mouse Model for Angiosarcoma
Oncotarget
Oncology
Antagonism of VEGF by Genetically Engineered Dendritic Cells Is Essential to Induce Antitumor Immunity Against Malignant Ascites
Molecular Cancer Therapeutics
Cancer Research
Oncology
A Dendritic Cell-Derived Receptor Counteracts Antitumor Immunity
Cancer Discovery
Oncology
Effective Antibody Therapy Induces Host-Protective Antitumor Immunity That Is Augmented by TLR4 Agonist Treatment
Cancer Immunology, Immunotherapy
Cancer Research
Medicine
Oncology
Allergy
Immunology
